Salih Sanlioglu
Chief Executive Officer at GenomCare- Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Gold Feature
Click to upgrade to our gold package
for the full feature experience.
Location
Turkey, TR
Topline Score
Bio
Generated by
Topline AI
No reviews to display
There are currently no reviews available.
No reviews to display
There are currently no reviews available.
No reviews to display
There are currently no reviews available.
No reviews to display
There are currently no reviews available.
0
/5.0 / Based on 0 ratingsFilter reviews by:
No reviews to display
There are currently no reviews available.
No reviews to display
There are currently no reviews available.
No reviews to display
There are currently no reviews available.
No reviews to display
There are currently no reviews available.
You need to have a working account to view this content.
Click here to join now
Experience
-
GenomCare
-
Türkiye
-
Biotechnology Research
-
1 - 100 Employee
-
Chief Executive Officer
-
Jun 2021 - Present
-
-
-
-
The Department Chair
-
Jan 2020 - Present
-
-
-
-
Prof. Dr.
-
2003 - Present
-
-
-
Akdeniz University
-
Türkiye
-
Higher Education
-
700 & Above Employee
-
Prof. Dr. of Department of Medical Biology and Genetics, Akdeniz University Faculty of Medicine
-
Jan 2008 - Present
-
-
-
-
Asc. Prof. Dr. of The Department of Medical Biology and Genetics
-
2002 - 2007
-
-
-
University of Iowa Hospitals and Clinics
-
United States
-
Medical Practices
-
1 - 100 Employee
-
Internal Medicine Research Fellow
-
1998 - 2001
Gene Therapy Center Gene Therapy Center
-
-
-
University of Pennsylvania School of Medicine
-
Higher Education
-
700 & Above Employee
-
Postdoc
-
1997 - 1998
Institute for Human Gene Therapy Institute for Human Gene Therapy
-
-
Education
-
The Ohio State University College of Medicine
PhD, Molecular Biology and Genetics -
The Ohio State University College of Medicine
MS, Molecular Biology and Genetics -
University of Selcuk
VMD, Veterinary Medicine
Community
You need to have a working account to view this content.
Click here to join now